Human intravenous immunoglobulins suppress seizure activities and inhibit the activation of GFAP-positive astrocytes in the hippocampus of picrotoxin-kindled rats

International Journal of Neuroscience

Volumn 122, Issue 4, 2012, Pages 200-208

  Li, Dongfang ^a   Li, Pinggan ^a   He, Zhanwen ^a   Cen, Danyang ^a   Meng, Zhe ^a   Liang, Liyang ^a   Luo, Xiangyang ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

glial fibrillary acidic protein (GFAP); human intravenous immunoglobulin; kindling; picrotoxin; seizure

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; IMMUNOGLOBULIN; PICROTOXIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; CELL ACTIVITY; CELL STRUCTURE; CONTROLLED STUDY; DISEASE SEVERITY; HIPPOCAMPUS; KINDLING; MALE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN STRUCTURE; RAT; SEIZURE;

ANIMALS; ASTROCYTES; CA1 REGION, HIPPOCAMPAL; CA2 REGION, HIPPOCAMPAL; CONVULSANTS; DENTATE GYRUS; GLIAL FIBRILLARY ACIDIC PROTEIN; HIPPOCAMPUS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; KINDLING, NEUROLOGIC; MALE; PICROTOXIN; RATS; RATS, WISTAR; SEIZURES;

EID: 84863282943     PISSN: 00207454     EISSN: 15635279     Source Type: Journal    
DOI: 10.3109/00207454.2011.639470     Document Type: Article

References (26)

1. Prince DA. Neurophysiology of epilepsy. Annu Rev Neurosci. 1978;1:395-415.
2. Tian GF, Azmi H, Takano T, Xu Q, Peng W, Lin J, Oberheim N, Lou N, Wang X, Zielke HR, Kang J, Nedergaard M. An astrocytic basis of epilepsy. Nat Med. 2005;11(9):973-81. (Pubitemid 41294443)
3. Luo X, Li D, Cen D, He Z, Meng Z, Liang L. Effect of intravenous immunoglobulin treatment on brain interferon-gamma and interleukin-6 levels in a rat kindling model. Epilepsy Res. 2010;88(2-3):162-7.
4. Bordey A, Sontheimer H. Properties of human glial cells associated with epileptic seizure foci. Epilepsy Res. 1998;32(1-2):286-303. (Pubitemid 28419497)
5. Tetzlaff W, GraeberMB, BisbyMA, Kreutzberg GW. Increased glial fibrillary acidic protein synthesis in astrocytes during retrograde reaction of the rat facial nucleus. Glia. 1988;1:90-95.
6. Mikati MA, Kurdi R, El-Khoury Z, Rahi A, Raad W. Intravenous immunoglobulin therapy in intractable childhood epilepsy: open-label study and review of the literature. Epilepsy Behav. 2010;17(1):90-94.
7. Van Engelen BG, Renier WO, Weemaes CM, Gabreels FJ, Meinardi H. Immunoglobulin treatment in epilepsy, a review of the literature. Epilepsy Res. 1994;19(3):181-90.
8. Loscher W. Animal models of epilepsy for the development of antiepileptogenic and disease-modifying drugs: A comparison of the pharmacology of kindling and post-status epilepticus models of temporal lobe epilepsy. Epilepsy Res. 2002;50(1-2):105-23. (Pubitemid 34876591)
9. Shandra AA, Mazarati AM, Godlevsky LS, Vastyanov RS. Chemical kindling: implications for antiepileptic drugs-sensitive and resistant epilepsy models. Epilepsia. 1996;37(3):269-74. (Pubitemid 26071828)
10. Racine RJ.Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr Clin Neurophysiol. 1972;32(3):281-94.
11. Cain DP. Kindling by repeated intraperitoneal or intracerebral injection of picrotoxin transfers to electrical kindling. Exp Neurol. 1987;97(2):243-54.
12. Paul V, Krishnamoorthy MS. The sex-related difference in the convulsant action of picrotoxin in rats. Indian J Physiol Pharmacol. 1988;32(3):221-2.
13. Diehl RG, Smialowski A, Gotwo T. Development and persistence of kindled seizures after repeated injections of pentylenetetrazol in rats and guinea pigs. Epilepsia. 1984;25(4):506-10. (Pubitemid 14050148)
14. Cifelli P, Grace AA. Pilocarpine-induced temporal lobe epilepsy in the rat is associated with increased dopamine neuron activity. Int J Neuropsychopharmacol. 2011;1-8, doi: 10.1017/S1461145711001106.
15. Damaye CA, Wu L, Peng J, He F, Zhang C, Lan Y, Walijee SM, Yin F. An experimental study on dynamic morphological changes and expression pattern of GFAP and synapsin I in the hippocampus of MTLE models for immature rats. Int J Neurosci. 2011;121:575-88.
16. Miltidous P, Stamatakis A, Koutsoudaki PN Tiniakos DG, Stylianopoulou F. IGF-I ameliorates hippocampal neurodegeration and protects in an animal model of temporal lobe epilepsy. Exper Neurol. 2011;231:223-35.
17. Lauritzen F, Perez EL, Melillo ER, Roh JM, Zaveri HP, Lee TS, Wang Y, Bergersen LH, Eid T. Altered expression of brain monocarboxylate tranporter 1 in models of temporal lobe epilepsy. Neurobiol Dis. 2011; doi: 10.1016/j.nbd.2011.08.001.
18. Shapiro LA,Wang L, Ribak CE. Rapid astrocyte and microglial activation following pilocarpine-induced seizures in rats. Epilepsia. 2008;49 Suppl 2:33-41. (Pubitemid 351143764)
19. Benarroch EE. Astrocyte-neuron interactions: implications for epilepsy. Neurology. 2009;73(16):1323-7.
20. Hinterkeuser S, Schroder W, HagerG, Seifert G, Bl̈umcke I, Elger CE, Schramm J, Steinḧauser C. Astrocytes in the hippocampus of patients with temporal lobe epilepsy display changes in potassium conductances. Eur J Neurosci. 2000;12(6):2087-96. (Pubitemid 30348846)
21. Lehtimaki KA, Peltola J, Koskikallio E, Ker̈anen T, Honkaniemi J. Expression of cytokines and cytokine receptors in the rat brain after kainic acid-induced seizures. Brain Res Mol Brain Res. 2003;110(2):253-60. (Pubitemid 36184697)
22. Ullian EM, Sapperstein SK, Christopherson KS, Barres BA. Control of synapse number by glia. Science. 2001;291(5504):657-61. (Pubitemid 32150425)
23. Heja L, Barabas P, Nyitrai G, Ḱekesi KA, Laszt́oczi B, Toke O, T́arḱanyi G, Madsen K, Schousboe A, Dobolyi A, Palkovits M, Kardos J. Glutamate uptake triggers transporter-mediated GABA release from astrocytes. PLoS One. 2009;4(9):e7153.
24. Girardi E, Ramos AJ, Vanore G, Brusco A. Astrocytic response in hippocampus and cerebral cortex in an experimental epilepsy model. Neurochem Res. 2004;29(2):371-7. (Pubitemid 38223017)
25. Billiau AD, Witters P, Ceulemans B, Kasran A, Wouters C, Lagae L. Intravenous immunoglobulins in refractory childhood-onset epilepsy: effects on seizure frequency, EEG activity, and cerebrospinal fluid cytokine profile. Epilepsia. 2007;48(9):1739-49. (Pubitemid 47352869)
26. Kazibutowska Z, Motta E, Húc M, Strzala-Orzel M, Wóznik G. [Serum levels of interleukin-6 and interleukin-10 in patients with multiple sclerosis during intravenous immunoglobulin infusion]. Wiad Lek. 2006;59(9-10):626-9 [in Polish].